Oragenics (0A64) Financial Statements
Oragenics Financial Overview
Oragenics's market cap is currently $1.69M. The company's EPS TTM is $-3.58; its P/E ratio is -0.10; Oragenics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -9.36M | $ -10.56M | $ -20.90M | $ -14.42M | $ -15.77M |
| EBITDA | $ 762.24M | $ -10.54M | $ -20.60M | $ -14.23M | $ -15.65M |
| Net Income | $ -9.84M | $ -10.57M | $ -20.66M | $ -14.29M | $ -15.71M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.40M | $ 864.84K | $ 3.48M | $ 11.43M | $ 27.27M |
| Total Assets | $ 10.07M | $ 1.47M | $ 4.97M | $ 14.76M | $ 28.23M |
| Total Debt | $ 227.35K | $ 328.53K | $ 322.51K | $ 624.53K | $ 797.21K |
| Net Debt | $ -4.17M | $ -536.31K | $ -3.16M | $ -10.80M | $ -26.47M |
| Total Liabilities | $ 1.79M | $ 1.68M | $ 1.80M | $ 1.75M | $ 1.74M |
| Stockholders' Equity | $ 8.28M | $ -211.88K | $ 3.17M | $ 13.01M | $ 26.49M |
| Cash Flow | |||||
| Free Cash Flow | $ -9.25B | $ -8.60M | $ -8.29M | $ -15.36M | $ -13.51M |
| Operating Cash Flow | $ -9.25B | $ -8.60M | $ -7.29M | $ -15.23M | $ -13.47M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -936.28K | $ -115.52K | $ -43.88K |
| Financing Cash Flow | $ 16.78B | $ 5.98M | $ 283.88K | $ -494.92K | $ 23.14M |
Currency in USD
